Volume : 11, Issue : 01, January – 2024
Title:
PHYTOCHEMICAL INVESTIGATION AND NEPHROPROTECTIVE ACTIVITY OF PHYLLANTHUS EMBLICA FRUIT EXTRACT
Authors :
Srujana.A
Abstract :
The present study was undertaken to scientifically evaluate the nephroprotective activity of the ethanolic extract of fruit pulps of Phyllanthus emblica. The phytochemical investigation revealed the presence of carbohydrate, alkaloids, flavanoids, glycosides, saponins, tannins, phenols and anthroquinone in EEPE.The administration of cisplatin during experimentation is effectively induced apoptosis and necrosis, which was similar to acute renal failure in human. Therefore, it is an effective and an ideal model for nephrotoxicity research. The evaluation of renal parameters on nephrotoxic rats with EEPE showed significantly elevate the attenuated body weight, urine volume, creatinine clearance and significantly reduce in elevated serum creatinine level, which supports its Nephroprotective activity. The cisplatin induced rats showed elevated levels of serum blood urea nitrogen (BUN) and lipid peroxidation parameter like malondialdehyde (MDA) which was significantly decreased with treatment of EEPE, which proves it having Nephroprotective activity. The Nephrotoxic rats also showed the reduced levels of enzymatic antioxidant like sulphoxide dismutase (SOD), glutathione peroxidise (GPx) and Catalase (CAT), and non-enzymatic antioxidant like Reduced glutathione (GSH), which was significantly increased with treatment of EEPE, which showed its antioxidant activity due to the Flavonoids which is present in the extract. Histopathological studies on isolated kidney revealed that the EEPE, reversed the kidney damage and also restored normal kidney architecture. The fruit pulp of Phyllanthus emblica in an ethanolic extract showed statistically significant nephroprotective activity.
Key words: Phytochemical Screening, Nephroprotective Activity, Phyllanthus emblica , Fruit Extract, Cisplatin Induced Nephrotoxicity.
Cite This Article:
Please cite this article in press Srujana.A., Phytochemical Investigation And Nephroprotective Activity Of Phyllanthus Emblica Fruit Extract , Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1. Little M.H., Combes A.N. Kidney organoids: Accurate models or fortunate accidents. Genes Dev. 2019;33:1319–1345. doi: 10.1101/gad.329573.119. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
2. Sujana D., Saptarini N.M., Sumiwi S.A., Levita J. Nephroprotective activity of medicinal plants: A review on in silico-, in vitro-, and in vivo-based studies. J. Appl. Pharm. Sci. 2021;11:113–127. doi: 10.7324/JAPS.2021.1101016. [CrossRef] [Google Scholar]
3. Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 2019;34:1803–1805. doi: 10.1093/ndt/gfz174. [PubMed] [CrossRef] [Google Scholar]
4. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 2020;52:1193–1194. doi: 10.1007/s11255-020-02451-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Chawla L.S., Bellomo R., Bihorac A., Goldstein S.L., Siew E.D., Bagshaw S.M., Bittleman D., Cruz D., Endre Z., Fitzgerald R.L., et al. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat. Rev. Nephrol. 2017;13:241–257. doi: 10.1038/nrneph.2017.2. [PubMed] [CrossRef] [Google Scholar]
6. KDIGO Kidney disease: Improving global outcomes (KDIGO) acute kidney injury workgroup. KDIGO clinical practice guideline for acute kidney injury. Kidney. Int. Suppl. 2012;2:1–138. [Google Scholar]
7. Manzoor H., Bhatt H. Prerenal Kidney Failure. StatPearls Publishing; Las Vegas, NV, USA: 2020. [Google Scholar]
8. Matuszkiewicz-Rowińska J., Małyszko J. Acute kidney injury, its definition, and treatment in adults: Guidelines and reality. Pol. Arch. Intern Med. 2020;130:1074–1080. doi: 10.20452/pamw.15373. [PubMed] [CrossRef] [Google Scholar]
9. Makris K., Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin. Biochem. Rev. 2016;37:85–98. [PMC free article] [PubMed] [Google Scholar]
10. Horie S., Oya M., Nangaku M., Yasuda Y., Komatsu Y., Yanagita M., Kitagawa Y., Kuwano H., Nishiyama H., Ishioka C., et al. Guidelines for treatment of renal injury during cancer chemotherapy 2016. Clin. Exp. Nephrol. 2018;22:210–244. doi: 10.1007/s10157-017-1448-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Lucas G.N.C., Leitão A.C.C., Alencar R.L., Xavier R.M.F., Daher E.D.F., Silva G.B.D. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J. Bras. Nefrol. 2019;41:124–130. doi: 10.1590/2175-8239-jbn-2018-0107. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Petejova N., Martinek A., Zadrazil J., Kanova M., Klementa V., Sigutova R., Kacirova I., Hrabovsky V., Svagera Z., Stejskal D. Acute kidney injury in septic patients treated by selected nephrotoxic antibiotic agents—Pathophysiology and biomarkers—A review. Int. J. Mol. Sci. 2020;21:7115. doi: 10.3390/ijms21197115. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Wu B., Li D., Xu T., Luo M., He Z., Li Y. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: Data mining of US FDA adverse event reporting system. Sci. Rep. 2021;11:1–8. doi: 10.1038/s41598-021-83099-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Lawson S.K., Satyal P., Setzer W.N. The volatile phytochemistry of seven native american aromatic medicinal plants. Plants. 2021;10:1061. doi: 10.3390/plants10061061. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Isah T. Stress and defense responses in plant secondary metabolites production. Biol. Res. 2019;52:39. doi: 10.1186/s40659-019-0246-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Das S., Vasudeva N., Sharma S. Kidney disorders and management through herbs: A Review. J. Phytopharm. 2019;8:21–27. doi: 10.31254/phyto.2019.8106. [CrossRef] [Google Scholar]
17. Efferth T., Saeed M.E., Mirghani E., Alim A., Yassin Z., Saeed E., Khalid H.E., Daak S. Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget. 2017;8:50284–50304. doi: 10.18632/oncotarget.17466. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
18. Governa P., Baini G., Borgonetti V., Cettolin G., Giachetti D., Magnano A.R., Miraldi E., Biagi M. Phytotherapy in the Management of Diabetes: A Review. Molecules. 2018;23:105. doi: 10.3390/molecules23010105. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
19. Sabiu S., O’Neill F.H., Ashafa A.O.T. The purview of phytotherapy in the management of kidney disorders: A systematic review on Nigeria and South Africa. Afr. J. Tradit. Complement. Altern. Med. 2016;13:38–47. [PMC free article] [PubMed] [Google Scholar]